LAB vs V · rev $174.4M vs P/E 33, rev $40.00B
Standard Biotools Inc (LAB) versus Visa Inc. Class A (V) — a side-by-side from cached financials, not a winner call.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Visa Inc. Class A (V) is a credit services company listed on US. It is led by Ryan McInerney.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
Latest reported V revenue for 2025-09-30 was $40.00B. Net income was $20.06B. V currently screens at market cap $659.78B and trailing P/E 33.5.
LAB currently screens at market cap $317.1M. V currently screens at market cap $659.78B and trailing P/E 33.5.
Not investment advice. Open the LAB and V stock pages for the full models.
Not investment advice.